bBHC achieved a patent for ‘liver cell differentiation using newly Elicited Pluripotent Stem Cells without side effects by natural compounds(nEPS)’ in the EU followed by Korea, America, and Australia.
bBHC achieved a patent for ‘liver cell differentiation using newly Elicited Pluripotent Stem Cells without side effects by natural compounds(nEPS)’ in the EU followed by Korea, America, and Australia.
